CYCLOHEXANAMINIUM ((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL HYDROGENDIPHOSPHATE

Suppliers

Names

[ CAS No. ]:
102029-87-8

[ Name ]:
CYCLOHEXANAMINIUM ((2R,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL)METHYL HYDROGENDIPHOSPHATE

[Synonym ]:
Adenosine 5'-diphosphate di(dicyclohexyl)amine salt

Chemical & Physical Properties

[ Molecular Formula ]:
C22H41N7O10P2

[ Molecular Weight ]:
625.54900

[ Exact Mass ]:
625.23900

[ PSA ]:
304.26000

[ LogP ]:
2.79140

MSDS

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xi

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
3.0

Articles

Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist.

Arterioscler. Thromb. Vasc. Biol. 31 , 416-422, (2011)

To investigate whether adenosine diphosphate (ADP)-derived adenosine might inhibit platelet aggregation, especially in the presence of a P2Y₁₂ antagonist, where the effects of ADP at the P2Y₁₂ recepto...

Extracellular Ca(2+) modulates ADP-evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation.

Br. J. Haematol. 153 , 83-91, (2011)

ADP is considered a weak platelet agonist due to the limited aggregation responses it induces in vitro at physiological concentrations of extracellular Ca(2+) [(Ca(2+) )(o) ]. Lowering [Ca(2+) ](o) pa...

P2Y receptors in health and disease.

Adv. Pharmacol. 61 , 417-439, (2011)

The purine- and pyrimidine-sensitive P2Y receptors belong to the large group of G-protein-coupled receptors that are the target of approximately one-third of the pharmaceutical drugs used in the clini...


More Articles


Related Compounds

  • Cyclohexylcarbamic acid-cyclohexanamine (1:1)
  • Cyclohexanaminium perfluorononanoate
  • Cyclohexanaminium (2S,3S)-2-azido-3-methylpentanoate
  • X-Gluc (Dicyclohexylamine)
  • 4-chloro-N-ethoxycarbonylbenzenesulfonimidate,cyclohexylazanium
  • CYCLOHEXYLAMMONIUM 1-[(S)-2-(TERT-BUTOXYCARBONYL)-3-(2-METHOXYETHOXY)PROPYL]CYCLOPENTANECARBOXYLATE
  • DANSYL-BETA-ALANINE CYCLOHEXYLAMMONIUM SALT
  • 3,6-Dimethoxy-2-fluoroaniline
  • 2,4-Dimethoxy-6-fluoroaniline
  • Methyl 4-isocyanato-3,3-dimethylbutanoate
  • (S)-Hexyl2-aminopropanoatehydrochloride
  • 4(1H)-Quinolinone, 2-(1,1,2,2-tetrafluoroethyl)-
  • 3-(3-Formyl-1H-pyrrol-1-yl)propanoic acid
  • (5-(4-Chlorophenyl)-1H-1,2,4-triazol-3-yl)(p-tolyl)methanamine
  • 2,2'-Bi-1H-pyrrole, 3,3',4-tribromo-4',5,5'-trichloro-1,1'-dimethyl-
  • 2-(5-chloro-1-ethyl-1H-pyrazol-4-yl)acetic acid
  • 2,2'-Bi-1H-pyrrole, 3,3',4,4',5-pentabromo-5'-chloro-1,1'-dimethyl-
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.